EUS-CPN: A Retrospective Review

This study has been completed.
Sponsor:
Information provided by:
Indiana University
ClinicalTrials.gov Identifier:
NCT00577564
First received: December 19, 2007
Last updated: September 11, 2012
Last verified: September 2012
  Purpose

The purpose of this retrospective study is to measure the safety of EUS-CPN in patients that have undergone this procedure in the last decade.


Condition
Pancreatic Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN): A Retrospective Review of Safety

Resource links provided by NLM:


Further study details as provided by Indiana University:

Primary Outcome Measures:
  • Number of EUS-CPN procedures for each patient [ Time Frame: over a ten year period ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Procedure-related complications [ Time Frame: over a ten year period ] [ Designated as safety issue: Yes ]

Study Start Date: July 2006
Study Completion Date: December 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All patients that underwent a EUS-CPN over a ten year period at Indiana University Medical Center will be considered.

Criteria

Inclusion Criteria:

  • Any subject that has undergone EUS-CPN will be considered for this study.

Exclusion Criteria:

  • Subjects will be excluded if they have undergone a celiac plexus neurolysis (endoscopic, percutaneous, or surgical) at an another institution.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00577564

Locations
United States, Indiana
Clarian: University Hospital
Indianpolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Investigators
Principal Investigator: Julia LeBlanc, MD, MPH Indiana University School of Medicine
  More Information

No publications provided

Responsible Party: Dr. Julia LeBlanc, Indiana University Medical Center
ClinicalTrials.gov Identifier: NCT00577564     History of Changes
Other Study ID Numbers: 0606-59, IRB #0606-59
Study First Received: December 19, 2007
Last Updated: September 11, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Pancreatic Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms
Neoplasms by Site
Pancreatic Diseases

ClinicalTrials.gov processed this record on October 21, 2014